MyCOPDTeam

Based on the provided search results, there is no information about any new COPD medication specifically approved for January 2025. However, the most recently approved medication mentioned is mepolizumab (Nucala), which is the first biologic medication approved for COPD patients with elevated eosinophil counts.

This Show Full Answer

Based on the provided search results, there is no information about any new COPD medication specifically approved for January 2025. However, the most recently approved medication mentioned is mepolizumab (Nucala), which is the first biologic medication approved for COPD patients with elevated eosinophil counts.

This medication is given as a monthly injection and works by targeting inflammation in people who continue to have COPD flare-ups despite using inhaled triple therapy. Clinical trials showed it reduced moderate and severe COPD flare-ups by 21%. If you're interested in learning about currently available COPD medications, there are several options including:

• Bronchodilators (both short-acting and long-acting)
• Corticosteroids
• Combination inhalers
• PDE4 inhibitors
• Alpha1-proteinase inhibitors (for specific cases)

 AI-generated responses are not a substitute for medical advice. These services are not intended to diagnose, treat, or cure any condition or disease. Always ask your doctor about specific health concerns.

First Biologic for Eosinophilic COPD Cuts Flare-Ups by 21%

Emphysema — An Overview